UHS — Universal Health Services price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $195.50
- YTD price return
- -10.33%
- YTD total return
- -10.01%
- Market cap
- 11.3B
- Enterprise value
- 17.4B
- Shares outstanding
- 57.7M
- 52W low
- $140.08
- 52W high
- $246.33
- From 52W high
- -20.63%
- From 52W low
- +39.56%
- 52W range
- 52%$140–$246
- Beta
- 1.06
Volume
- Rel volume
- 1.05×
- 30D volume
- 706.5K
- 30D $ vol
- 128.6M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$128K
Form 4 transactions by trade date, as filed; latest on file 2026-03-13.
Fundamentals
- Sales (ttm)
- 18.4B
- Sales/share
- $318.33
- EPS (ttm)
- $23.97
- FCF (ttm)
- 1.1B
- FCF/share
- $19.34
- Book value/share
- $131.77
- Net margin
- 7.96%
- ROE
- 19.24%
- ROA
- 8.51%
- Debt / equity
- 0.74×
- Current ratio
- 1.37
Growth (CAGR, ttm) · 10Y
- Sales
- +8.01%+9.38%+8.06%+6.69%
- Net income
- +6.29%+29.29%+6.62%+7.61%
- FCF
- +15.19%+39.40%n/a+2.69%
- Shares
- -7.74%-5.47%-6.43%-5.20%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +14.09%+35.98%+14.06%+12.94%
- Sales/share
- +17.07%+15.71%+15.49%+12.54%
- FCF/share
- +24.85%+47.48%n/a+8.32%
- Book value/share
- +14.85%+14.03%+11.04%+11.42%
- Dividend/share
- +0.00%+0.00%+6.27%+7.32%
- Price
- -13.65%+14.66%+8.52%+4.97%
- Total return
- -13.28%+15.17%+9.08%+5.42%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 8.2×
- P/OI (ttm)
- 5.7×
- Fwd P/E
- 8.6×
- P/S (ttm)
- 0.6×
- P/B (mrq)
- 1.5×
- P/FCF (ttm)
- 10.1×
- EV/EBITDA (fy)
- 6.6×
- EV/Sales (ttm)
- 0.9×
- FCF yield (ttm)
- 9.89%
- Dividend yield (fwd)Div yield
- 0.41%
- Dividend yield (ttm)
- 0.41%
- Dividend/share (fwd)
- $0.80
- Buyback yield (realized, 1y)
- 7.74%
- Shareholder yield (realized, 1y)
- 8.12%
- Buyback yield (cash, ttm)
- 9.44%
- Shareholder yield (cash, ttm)
- 9.88%
Vs own 10Y history
- P/E
- 6th
- P/OI
- 6th
- P/S
- 10th
- P/B
- 15th
- P/FCF
- 14th
Bar = where today’s multiple sits in UHS’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +8.0%10Y CAGR +4.7%YoY −12.9%EPS (diluted)
5Y CAGR +16.0%10Y CAGR +13.1%YoY −10.9%Free cash flow
5Y CAGR −12.2%10Y CAGR +2.1%YoY +177.8%TTM: operating cash flow $2.1B, capex −$941M
Q3 2026: operating cash flow $636.6M, capex −$214.9M
Shares (diluted)
5Y −24.7%10Y −36.0%YoY −7.1%Dividend per share
5Y CAGR +31.6%10Y CAGR +7.4%YoY +0.0%About Universal Health Services#
Data provided bySource: Twelve DataUniversal Health Services Inc. Class B Common Stock represents an equity interest in Universal Health Services, a healthcare services company that owns and operates acute care hospitals, behavioral health facilities, surgical hospitals, ambulatory surgery centers, and related outpatient care centers. Universal Health Services serves patients through a broad network of medical and behavioral health services, including emergency care, specialty medicine, diagnostic imaging, surgery, rehabilitation, psychiatric treatment, and addiction-focused programs. The company’s operations are organized around hospital-based and behavioral health segments, supported by centralized management and administrative services that help coordinate clinical delivery, purchasing, finance, and facility operations. Universal Health Services plays a significant role in the U.S. healthcare market by providing essential inpatient and outpatient services across multiple care settings and patient needs.
King of Prussia, PA·101,500 employees·Medical Care Facilities·uhs.com·As of Oct 28, 2026
Recent filings#
- Oct 27Earnings · Earnings release — EPS $5.22 vs $5.31 est. (−1.7%); revenue $4.73B (+5% y/y) 2.9%
- Aug 178-K · Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.
- Aug 7Report · Quarterly report, Q2 2026 — revenue $4.64B (+8% y/y), net income $358.4M, EPS $5.98
- Jul 288-K · ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST
ETFs holding UHS#
27 of the 193 ETFs ChartRow carries live hold UHS. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VBR | Vanguard Small-Cap Value ETF | 0.2% |
| XLV | Health Care Select Sector SPDR Fund | 0.1% |
| VHT | Vanguard Health Care ETF | 0.1% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.0% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
